Cypress Announces Pilot Program With HemaCare Program Makes PROSORBA Column Treatment More Accessible to Physicians.
Business Wire › March 13, 2000
Linked as:
Extract
Cypress Announces Pilot Program With HemaCare Program Makes PROSORBA Column Treatment More Accessible to Physicians.
Business Editors/Health and Medical Writers
SAN DIEGO--(BW HealthWire)--March 13, 2000 Cypress Bioscience Inc. (Nasdaq:CYPB) today announced a cooperative program with HemaCare (OTCBB:HEMA), one of the leading providers of apheresis treatments in the country, to offer more convenient delivery of PROSORBA(R) column treatments. The agreement with HemaCare pr...See the full content of this document
Sponsored links
